Transgenic mice overexpressing FGF23 have decreased urinary phosphate reabsorption, hypophosphatemia, low serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels, and hyperparathyroidism [5,6]. This evidence concerns the gene FGF23 and hypophosphatemia.